Skip to main content
logo
Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
114.83
+0.03 (0.03%)
At close: Apr 10, 2026, 4:00 PM EDT
114.85
+0.02 (0.02%)
After-hours: Apr 10, 2026, 4:47 PM EDT

Arcellx Revenue

In the year 2025, Arcellx had annual revenue of $22.29M, down -79.35%. Arcellx had revenue of $1.65M in the quarter ending December 31, 2025, a decrease of -89.17%.

Revenue (ttm)
$22.29M
Revenue Growth
-79.35%
P/S Ratio
302.31
Revenue / Employee
$106,632
Employees
209
Market Cap
6.74B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202522.29M-85.65M-79.35%
Dec 31, 2024107.94M-2.38M-2.16%
Dec 31, 2023110.32M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
PTC Therapeutics1.73B
Halozyme Therapeutics1.40B
Mirum Pharmaceuticals521.31M
ImmunityBio113.29M
Protagonist Therapeutics46.02M
Kymera Therapeutics39.21M
Centessa Pharmaceuticals15.00M
Revenue Rankings

ACLX News

More News